Blogs

Blogs

Blogs

ToxiProofAI: Predictive Safety Intelligence for Safer Drug Development

ToxiProofAI is redefining how drug discovery teams predict, monitor, and mitigate safety risks across the drug development lifecycle. Built specifically …

Read More →

Q&A Immuno-Oncology and Biomarker Summit London: Amit from Bioflares

1. In your view, what are the most significant recent trends and advancements in immuno-oncology and biomarker science — particularly …

Read More →

Advancing High-Potency Manufacturing: FPS Pharma as Gold Sponsor at the 2nd Annual EuroPotent 360 Summit

As the pharmaceutical industry propels forward with transformative therapies and next-generation drug manufacturing, safety, precision, and innovation have never been …

Read More →
Insights from Thomas Adam, Head of Global QA, Chemical APIs, Bayer, Germany

How Digital Health Technologies Are Revolutionizing Real-World Evidence (RWE) Collection and Utilization

The integration of digital health technologies is dramatically transforming how real-world evidence (RWE) is collected, analyzed, and applied across the …

Read More →

Advanced Containment: Innovations Shaping the Future of HPAPI Facilities

As the pharmaceutical industry continues to embrace highly potent active pharmaceutical ingredients (HPAPIs), ensuring safety and operational efficiency has never …

Read More →

Harnessing Innovation in HPAPIs: Breakthroughs, Challenges, and Future Perspectives

Highly Potent Active Pharmaceutical Ingredients (HPAPIs) are at the forefront of reshaping therapeutic development, offering groundbreaking treatments that are more …

Read More →